StockMacro
Menu

Entrada Therapeutics

$4.35 -35% in 6 monthsMarket cap $170.3M

TRDA on XNAS, Health Care, Entrada Therapeutics, Inc., job postings

Measures activity, not value. Not investment advice.

Revenue fell 94% over 12 months as short interest hit 3.5 times last year's level.

  • BadNet loss of $161.4M over 12 months, against $193M cash
  • BadInsiders sold $3.6M in 90 days and bought nothing

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

Industry
Pharmaceutical preparations (Health Care)
Employees
152
Website
entradatx.com
Listed
Nasdaq, US
Last results
5 Nov 2026
Next results
expected around 7 Jan 2027 (an estimate: a year ago it reported on 8 Jan 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $905K, net loss $39.7M.
Quarter to 31 Dec 2021: revenue –, net income -$18.4MQuarter to 31 Mar 2022: revenue $0, net income -$21.7MQuarter to 31 Mar 2022: revenue $0, net income -$21.7MQuarter to 30 Jun 2022: revenue $0, net income -$23.2MQuarter to 30 Jun 2022: revenue $0, net income -$23.2MQuarter to 30 Sep 2022: revenue $0, net income -$25.1MQuarter to 30 Sep 2022: revenue $0, net income -$25.1MQuarter to 31 Dec 2022: revenue –, net income -$24.6MQuarter to 31 Mar 2023: revenue $25.3M, net income -$6.7MQuarter to 31 Mar 2023: revenue $25.3M, net income -$6.7MQuarter to 30 Jun 2023: revenue $18.2M, net income -$25.9MQuarter to 30 Jun 2023: revenue $18.2M, net income -$25.9MQuarter to 30 Sep 2023: revenue $43.7M, net income $35.5MQuarter to 30 Sep 2023: revenue $43.7M, net income $35.5MQuarter to 31 Dec 2023: revenue $41.8M, net income -$9.5MQuarter to 31 Dec 2023: revenue $41.8M, net income -$9.5MQuarter to 31 Mar 2024: revenue $59.1M, net income $23.5MQuarter to 31 Mar 2024: revenue $59.1M, net income $23.5MQuarter to 30 Jun 2024: revenue $94.7M, net income $55.0MQuarter to 30 Jun 2024: revenue $94.7M, net income $55.0MQuarter to 30 Sep 2024: revenue $19.6M, net income -$14.0MQuarter to 30 Sep 2024: revenue $19.6M, net income -$14.0MQuarter to 31 Dec 2024: revenue $37.4M, net income $1.1MQuarter to 31 Dec 2024: revenue $37.4M, net income $1.1MQuarter to 31 Mar 2025: revenue $20.6M, net income -$17.3MQuarter to 31 Mar 2025: revenue $20.6M, net income -$17.3MQuarter to 30 Jun 2025: revenue $1.9M, net income -$43.1MQuarter to 30 Jun 2025: revenue $1.9M, net income -$43.1MQuarter to 30 Sep 2025: revenue $1.6M, net income -$44.1MQuarter to 30 Sep 2025: revenue $1.6M, net income -$44.1MQuarter to 31 Dec 2025: revenue $1.3M, net income -$39.2MQuarter to 31 Dec 2025: revenue $1.3M, net income -$39.2MQuarter to 31 Mar 2026: revenue $875K, net income -$39.7MQuarter to 31 Mar 2026: revenue $875K, net income -$39.7MQuarter to 30 Jun 2026: revenue $898K, net income -$42.8MQuarter to 30 Jun 2026: revenue $898K, net income -$42.8MQuarter to 30 Sep 2026: revenue $905K, net income -$39.7MQuarter to 30 Sep 2026: revenue $905K, net income -$39.7M
31 Dec 2021RevenueNet incomeNet losstallest bar $94.7M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$905K-$39.7M
30 Jun 2026$898K-$42.8M
31 Mar 2026$875K-$39.7M
31 Dec 2025$1.3M-$39.2M
30 Sep 2025$1.6M-$44.1M
30 Jun 2025$1.9M-$43.1M
31 Mar 2025$20.6M-$17.3M
31 Dec 2024$37.4M$1.1M
30 Sep 2024$19.6M-$14.0M
30 Jun 2024$94.7M$55.0M
31 Mar 2024$59.1M$23.5M
31 Dec 2023$41.8M-$9.5M
30 Sep 2023$43.7M$35.5M
30 Jun 2023$18.2M-$25.9M
31 Mar 2023$25.3M-$6.7M
31 Dec 2022–-$24.6M
30 Sep 2022$0-$25.1M
30 Jun 2022$0-$23.2M
31 Mar 2022$0-$21.7M
31 Dec 2021–-$18.4M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $4.0M $61.5M
Revenue growthRevenue of the last 12 months compared with the 12 months before. -94% +11%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$161.4M -$103.5M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). -$3.84 -$2.56
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. – – 73.2%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. – -198% -25.0%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. – -168% -18.2%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -59.9% -58.8%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. – –
CashCash, cash equivalents and short-term investments on the latest balance sheet. $193.0M $326.8M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $0 $0
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). -$193.0M (net cash) -$326.8M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.0 0.0
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $5.07
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 19.3
P/SPrice to sales: market cap divided by revenue of the last 12 months. 42.8 5.0
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. – 5.0
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 0.86 2.0

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
Entrada TherapeuticsTRDA (this company) $170.3Mloss42.8-94%–
SIGA TechnologiesSIGA $172.5M2513.3-70%1.3%
Korro BioKRRO $167.2Mloss129-82%–
Abeona TherapeuticsABEO $165.3Mloss3.5–-160%
VogenxVOGX $176.3M––––
Nature's Sunshine ProductsNATR $176.4M12.00.37+1.2%3.1%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

-$3.6M

bought $0, sold $3.6M

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+1.6%

129 13F filers vs 127

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

77%

30.1M shares held by 13F filers (30 Sep 2026) of 39.2M outstanding (31 Oct 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

7.2%

2.8M shares sold short (30 Oct 2026) of 39.2M outstanding (31 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

6.9

2.8M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-14%

3.3M shares sold short in the report before, 2.8M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

63%

63% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 43%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

6

Tracked since 20 Nov 2026

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

Tracking started 20 Nov 2026; the change shows after 30 days.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

–

No data for this company

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

–

No data for this company

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

–

No data for this company

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

8

8 articles in the last 7 days; its usual week has 1 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

8.0×

8 articles in the last 7 days; its usual week has 1.

Unusual now sharp changes in the last 90 days, compared with its own past

  • Short interest 3.3M, 3.5× a year earlier

Price $4.35 on 20 Nov 2026, -53% over 12 months (12-month range $4.35 to $16.03)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders sold a net $7.9M in the last 12 months (the 12 months before: -$5.2M).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 7 published in the last 12 months, 0% on the 12 months before.
Revenue per quarter. Revenue $905K in the latest quarter, -44% on a year earlier.
Capital spending per quarter. Capital spending $161K in the latest quarter.
Institutional holders (13F filers). 129 13F filers reported holding it in the latest 13F quarter, +15% on a year earlier.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: federal obligations, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
17 Nov 2026Sharp changeShort interest spike: short interest spike, 2.8M vs usual 973K (2026-10-30); 3.1x the same period a year earlier
27 Oct 2026Sharp changeShort interest spike: short interest spike, 3.3M vs usual 946K (2026-10-15); 3.5x the same period a year earlier
13 Oct 2026Sharp changeShort interest spike: short interest spike, 3.0M vs usual 935K (2026-09-30); 3.7x the same period a year earlier
29 Sep 2026Sharp changeShort interest spike: short interest spike, 2.7M vs usual 935K (2026-09-15); 2.6x the same period a year earlier
15 Sep 2026Sharp changeShort interest spike: short interest spike, 2.3M vs usual 935K (2026-08-31); 2.2x the same period a year earlier
1 Sep 2026Sharp changeShort interest spike: short interest spike, 2.4M vs usual 935K (2026-08-14); 2.2x the same period a year earlier
18 Aug 2026Sharp changeShort interest spike: short interest spike, 2.1M vs usual 935K (2026-07-31); 1.9x the same period a year earlier
16 Jun 2026Sharp changeShort interest spike: short interest spike, 1.7M vs usual 935K (2026-05-29); 1.6x the same period a year earlier
10 Jun 20268-K and other filingsDirector or officer change
10 Jun 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
2 Jun 2026Sharp changeShort interest spike: short interest spike, 1.5M vs usual 935K (2026-05-15); 1.4x the same period a year earlier
3 Jun 20258-K and other filingsDirector or officer change
3 Jun 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
29 Apr 20258-K and other filingsRestructuring costs announced
3 Jan 20248-K and other filingsDirector or officer change
12 Dec 2023Sharp changeShort interest spike: short interest spike, 1.8M vs usual 1.2M (2023-11-30); 1.6x the same period a year earlier
6 Dec 20238-K and other filingsDirector or officer change
6 Dec 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
28 Nov 2023Sharp changeShort interest spike: short interest spike, 1.7M vs usual 1.2M (2023-11-15); 1.4x the same period a year earlier
14 Nov 2023Sharp changeShort interest spike: short interest spike, 1.7M vs usual 1.2M (2023-10-31); 1.6x the same period a year earlier
31 Oct 2023Sharp changeShort interest spike: short interest spike, 1.7M vs usual 1.1M (2023-10-13); 1.5x the same period a year earlier
17 Oct 2023Sharp changeShort interest spike: short interest spike, 1.6M vs usual 1.1M (2023-09-29); 1.5x the same period a year earlier
19 Sep 2023Sharp changeShort interest spike: short interest spike, 1.5M vs usual 1.1M (2023-08-31); 1.4x the same period a year earlier
29 Aug 2023Sharp changeShort interest spike: short interest spike, 1.6M vs usual 1.1M (2023-08-15); 1.4x the same period a year earlier
15 Aug 2023Sharp changeShort interest spike: short interest spike, 1.6M vs usual 1.1M (2023-07-31); 1.3x the same period a year earlier
10 Aug 20238-K and other filingsDirector or officer change
1 Aug 2023Sharp changeShort interest spike: short interest spike, 1.6M vs usual 1.1M (2023-07-14); 1.1x the same period a year earlier
18 Jul 2023Sharp changeShort interest spike: short interest spike, 1.6M vs usual 1.1M (2023-06-30); 1.0x the same period a year earlier
8 Jun 20238-K and other filingsDirector or officer change
4 Apr 20238-K and other filingsDirector or officer change
4 Apr 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
Insider net buying (open market)
Month from 1 Jan 2022: $49K published
Month from 1 May 2022: $713K published
Month from 1 Jun 2022: $112K published
Month from 1 Jul 2022: -$24K published
Month from 1 Aug 2022: -$225K published
Month from 1 Sep 2022: -$629K published
Month from 1 Oct 2022: -$987K published
Month from 1 Nov 2022: -$54K published
Month from 1 Dec 2022: -$390K published
Month from 1 Jan 2023: -$130K published
Month from 1 Mar 2023: -$89K published
Month from 1 Apr 2023: -$109K published
Month from 1 May 2023: -$27K published
Month from 1 Jun 2023: -$509K published
Month from 1 Jul 2023: -$630K published
Month from 1 Aug 2023: -$410K published
Month from 1 Sep 2023: -$53K published
Month from 1 Oct 2023: -$15K published
Month from 1 Nov 2023: -$16K published
Month from 1 Dec 2023: -$210K published
Month from 1 Jan 2024: -$16K published
Month from 1 Feb 2024: -$15K published
Month from 1 Mar 2024: $85K published
Month from 1 Apr 2024: $56K published
Month from 1 May 2024: $95K published
Month from 1 Jun 2024: -$16K published
Month from 1 Jul 2024: -$82K published
Month from 1 Aug 2024: -$441K published
Month from 1 Sep 2024: -$132K published
Month from 1 Oct 2024: -$24K published
Month from 1 Nov 2024: -$594K published
Month from 1 Dec 2024: -$1.4M published
Month from 1 Mar 2025: -$19K published
Month from 1 Jul 2025: -$1.9M published
Month from 1 Nov 2025: -$2.0M published
Month from 1 Mar 2026: -$508K published
Month from 1 Apr 2026: -$32K published
Month from 1 May 2026: -$599K published
Month from 1 Aug 2026: -$3.6M published
Month from 1 Sep 2026: -$3.1M published
H-1B/E-3 applications certified
Quarter from 1 Jul 2022: 6 published
Quarter from 1 Jul 2023: 4 published
Quarter from 1 Apr 2024: 13 published
Quarter from 1 Jul 2024: 1 published
Quarter from 1 Apr 2025: 1 published
Quarter from 1 Jul 2025: 5 published
Quarter from 1 Oct 2025: 1 published
Quarter from 1 Jul 2026: 6 published
Quarter from 1 Oct 2026: 1 published
Revenue per quarter
Quarter ended 31 Mar 2022: $0; public on 11 May 2023
Quarter ended 30 Jun 2022: $0; public on 9 Aug 2023
Quarter ended 30 Sep 2022: $0; public on 8 Nov 2023
Quarter ended 31 Mar 2023: $25.3M; public on 11 May 2023
Quarter ended 30 Jun 2023: $18.2M; public on 9 Aug 2023
Quarter ended 30 Sep 2023: $43.7M; public on 8 Nov 2023
Quarter ended 31 Dec 2023: $41.8M; public on 14 Mar 2024
Quarter ended 31 Mar 2024: $59.1M, +134% on a year earlier; public on 8 May 2024
Quarter ended 30 Jun 2024: $94.7M, +421% on a year earlier; public on 14 Aug 2024
Quarter ended 30 Sep 2024: $19.6M, -55% on a year earlier; public on 6 Nov 2024
Quarter ended 31 Dec 2024: $37.4M, -11% on a year earlier; public on 28 Feb 2025
Quarter ended 31 Mar 2025: $20.6M, -65% on a year earlier; public on 9 May 2025
Quarter ended 30 Jun 2025: $1.9M, -98% on a year earlier; public on 7 Aug 2025
Quarter ended 30 Sep 2025: $1.6M, -92% on a year earlier; public on 7 Nov 2025
Quarter ended 31 Dec 2025: $1.3M, -97% on a year earlier; public on 27 Feb 2026
Quarter ended 31 Mar 2026: $875K, -96% on a year earlier; public on 8 May 2026
Quarter ended 30 Jun 2026: $898K, -54% on a year earlier; public on 6 Aug 2026
Quarter ended 30 Sep 2026: $905K, -44% on a year earlier; public on 6 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2020: $1.4M; public on 16 Mar 2022
Quarter ended 31 Mar 2021: $908K; public on 13 May 2022
Quarter ended 30 Jun 2021: $1.5M; public on 12 Aug 2022
Quarter ended 30 Sep 2021: $806K; public on 10 Dec 2021
Quarter ended 31 Dec 2021: $1.3M, -8.4% on a year earlier; public on 16 Mar 2022
Quarter ended 31 Mar 2022: $594K, -35% on a year earlier; public on 13 May 2022
Quarter ended 30 Jun 2022: $775K, -50% on a year earlier; public on 12 Aug 2022
Quarter ended 30 Sep 2022: $810K, +0.5% on a year earlier; public on 8 Nov 2022
Quarter ended 31 Dec 2022: $708K, -46% on a year earlier; public on 7 Mar 2023
Quarter ended 31 Mar 2023: $1.7M, +181% on a year earlier; public on 11 May 2023
Quarter ended 30 Jun 2023: $1.5M, +96% on a year earlier; public on 9 Aug 2023
Quarter ended 30 Sep 2023: $1.4M, +79% on a year earlier; public on 8 Nov 2023
Quarter ended 31 Dec 2023: $976K, +38% on a year earlier; public on 14 Mar 2024
Quarter ended 31 Mar 2024: $838K, -50% on a year earlier; public on 8 May 2024
Quarter ended 30 Jun 2024: $1.0M, -31% on a year earlier; public on 14 Aug 2024
Quarter ended 30 Sep 2024: $639K, -56% on a year earlier; public on 6 Nov 2024
Quarter ended 31 Dec 2024: $635K, -35% on a year earlier; public on 28 Feb 2025
Quarter ended 30 Jun 2025: $275K, -74% on a year earlier; public on 7 Aug 2025
Quarter ended 31 Mar 2026: $44K; public on 8 May 2026
Quarter ended 30 Jun 2026: $11K, -96% on a year earlier; public on 6 Aug 2026
Quarter ended 30 Sep 2026: $161K; public on 6 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 44; public on 14 Feb 2022
31 Mar 2022 report: 46; public on 16 May 2022
30 Jun 2022 report: 38; public on 15 Aug 2022
30 Sep 2022 report: 30; public on 14 Nov 2022
31 Dec 2022 report: 46; public on 14 Feb 2023
31 Mar 2023 report: 50; public on 15 May 2023
30 Jun 2023 report: 52; public on 14 Aug 2023
30 Sep 2023 report: 53; public on 14 Nov 2023
31 Dec 2023 report: 59; public on 14 Feb 2024
31 Mar 2024 report: 76; public on 15 May 2024
30 Jun 2024 report: 80; public on 14 Aug 2024
30 Sep 2024 report: 94; public on 14 Nov 2024
31 Dec 2024 report: 99; public on 14 Feb 2025
31 Mar 2025 report: 106; public on 15 May 2025
30 Jun 2025 report: 102; public on 14 Aug 2025
30 Sep 2025 report: 112; public on 14 Nov 2025
31 Dec 2025 report: 111; public on 17 Feb 2026
31 Mar 2026 report: 116; public on 15 May 2026
30 Jun 2026 report: 127; public on 14 Aug 2026
30 Sep 2026 report: 129; public on 16 Nov 2026

What is unusual now

  • Made public in the last 90 days: it had 3.3M shares sold short in the 15 Oct 2026 report, 3.5× the same report last year; it also had 3.0M shares sold short in the 30 Sep 2026 report, 3.7× the same report last year. 6 sharp changes in all.
  • Short interest spike: had 3.3M shares sold short in the 15 Oct 2026 report, 3.5× the same report last year Public on 27 Oct 2026.
  • Insider net buying (open market): Insiders sold a net $7.9M in the last 12 months (the 12 months before: -$5.2M).
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 7 published in the last 12 months, 0% on the 12 months before.

Latest records

The names and amounts behind the totals, newest first

Last 90 days: 4 sales, $3.6M; no purchases. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
9 Sep 2026MPM Bioventures 2018 (B), L.P. and 9 others10% ownerSell259,837$7.33$1.9MForm 4
3 Sep 2026MPM BioVentures 2014 GP LLC and 9 others10% ownerSell86,482$7.14$617KForm 4
31 Aug 2026MPM BioVentures 2014 (B), L.P. and 9 others10% ownerSell86,914$7.08$616KForm 4
26 Aug 2026MPM BioVentures 2018 LLC and 2 others10% ownerSell62,714$7.36$462KForm 4
10 Aug 2026Kush ParmarDirectorSell155,255$6.95$1.1MForm 4
10 Aug 2026Scott M Rocklage and 5 others10% ownerSell62,811$6.88$432KForm 4
3 Aug 2026Kush ParmarDirector, 10% ownerSell116,474$6.93$807KForm 4
3 Aug 2026Scott M Rocklage and 5 others10% ownerSell116,474$6.93$807KForm 4

129 institutions reported shares at the end of Q3 2026, 77% of the shares outstanding; 16 opened a position, 13 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
Baker Bros. Advisors LP5.1M13.0%$32.2MNo change
5AM Venture Management, LLC3.8M9.67%$24.0M-272K-6.7%
BlackRock, Inc.3.2M8.27%$20.6M+654K+25%
Merck & Co., Inc.1.7M4.44%$11.0MNo change
Trails Edge Capital Partners, LP1.4M3.65%$9.1MNew+1.4M
Vanguard Capital Management LLC1.3M3.24%$8.1MNo change
TCG Crossover Management, LLC1.1M2.71%$6.7MNo change
Wellington Management Group LLP954K2.44%$6.1MNo change
StepStone Group LP761K1.94%$4.8MNo change
Geode Capital Management, LLC708K1.81%$4.5M-8,940-1.2%

Company events

All 18 company events

In 12 months: 1 director or officer change. Results releases and routine reports are left out.

FiledWhat happenedSource
10 Jun 2026Director or officer changeSame filing: shareholder vote results8-K
3 Jun 2025Director or officer change8-K
29 Apr 2025Restructuring costs announced8-K
24 Jun 2024Signed a major agreement8-K
3 Jan 2024Director or officer change8-K
6 Dec 2023Director or officer change8-K
1 Nov 2023Signed a major agreement8-K
29 Sep 2023Signed a major agreement8-K

6 open postings; careers site tracked since 20 Nov 2026. Most in Legal, policy & compliance 33%, Data & analytics 17%, Research & science 17%, Supply chain & procurement 17%.

PostedJobLocation
13 Nov 2026Senior Manager, Clinical Supply ChainSupply chain & procurementBoston, MA
20 Oct 2026Clinical Pharmacology ConsultantLegal, policy & complianceBoston, MA
16 Oct 2026Manager, Commercial Strategy AnalyticsData & analyticsBoston, MA
15 Oct 2026Clinical Scientist (CONSULTANT)Research & scienceBoston, MA
1 Sep 2026Associate Director, Analytical Development & Quality ControlTest, quality & reliabilityBoston, MA
1 Sep 2026Director, Regulatory WritingLegal, policy & complianceBoston, MA

The 5 newest of 70 articles that name the company.

Timeline
Kind of data

Timeline

Changes and notable records, by the date each became public

  1. 11 Nov 2026Short interest and volume change

    had 2.8M shares sold short in the 30 Oct 2026 report, 3.1× the same report last year.

    Same report last year: 894K; its normal report is 973K.

    See the evidence
    This period
    2.8M (the 30 Oct 2026 report)
    Normal report (median of 24 earlier)
    973K
    Typical spread (median absolute deviation)
    182K
    How far from its usual level
    +6.8
    Same report last year
    894K
    History used
    1,810 days
    2025-10-31: 894K2025-11-14: 926K2025-11-28: 949K2025-12-15: 899K2025-12-31: 760K2026-01-15: 858K2026-01-30: 896K2026-02-13: 909K2026-02-27: 823K2026-03-13: 924K2026-03-31: 894K2026-04-15: 852K2026-04-30: 998K2026-05-15: 1.5M2026-05-29: 1.7M2026-06-15: 1.9M2026-06-30: 2.1M2026-07-15: 2.2M2026-07-31: 2.1M2026-08-14: 2.4M2026-08-31: 2.3M2026-09-15: 2.7M2026-09-30: 3.0M2026-10-15: 3.3M2026-10-30: 2.8M
    the 30 Oct 2026 report24 earlier reportsnormal: 973K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  2. 27 Oct 2026Short interest and volume change

    had 3.3M shares sold short in the 15 Oct 2026 report, 3.5× the same report last year.

    Same report last year: 944K; its normal report is 946K.

    See the evidence
    This period
    3.3M (the 15 Oct 2026 report)
    Normal report (median of 24 earlier)
    946K
    Typical spread (median absolute deviation)
    109K
    How far from its usual level
    +14.4
    Same report last year
    944K
    History used
    1,795 days
    2025-10-15: 944K2025-10-31: 894K2025-11-14: 926K2025-11-28: 949K2025-12-15: 899K2025-12-31: 760K2026-01-15: 858K2026-01-30: 896K2026-02-13: 909K2026-02-27: 823K2026-03-13: 924K2026-03-31: 894K2026-04-15: 852K2026-04-30: 998K2026-05-15: 1.5M2026-05-29: 1.7M2026-06-15: 1.9M2026-06-30: 2.1M2026-07-15: 2.2M2026-07-31: 2.1M2026-08-14: 2.4M2026-08-31: 2.3M2026-09-15: 2.7M2026-09-30: 3.0M2026-10-15: 3.3M
    the 15 Oct 2026 report24 earlier reportsnormal: 946K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  3. 10 Oct 2026Short interest and volume change

    had 3.0M shares sold short in the 30 Sep 2026 report, 3.7× the same report last year.

    Same report last year: 813K; its normal report is 935K.

    See the evidence
    This period
    3.0M (the 30 Sep 2026 report)
    Normal report (median of 24 earlier)
    935K
    Typical spread (median absolute deviation)
    98K
    How far from its usual level
    +14.2
    Same report last year
    813K
    History used
    1,780 days
    2025-09-30: 813K2025-10-15: 944K2025-10-31: 894K2025-11-14: 926K2025-11-28: 949K2025-12-15: 899K2025-12-31: 760K2026-01-15: 858K2026-01-30: 896K2026-02-13: 909K2026-02-27: 823K2026-03-13: 924K2026-03-31: 894K2026-04-15: 852K2026-04-30: 998K2026-05-15: 1.5M2026-05-29: 1.7M2026-06-15: 1.9M2026-06-30: 2.1M2026-07-15: 2.2M2026-07-31: 2.1M2026-08-14: 2.4M2026-08-31: 2.3M2026-09-15: 2.7M2026-09-30: 3.0M
    the 30 Sep 2026 report24 earlier reportsnormal: 935K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  4. 25 Sep 2026Short interest and volume change

    had 2.7M shares sold short in the 15 Sep 2026 report, 2.6× the same report last year.

    Same report last year: 1.1M; its normal report is 935K.

    See the evidence
    This period
    2.7M (the 15 Sep 2026 report)
    Normal report (median of 24 earlier)
    935K
    Typical spread (median absolute deviation)
    98K
    How far from its usual level
    +12.5
    Same report last year
    1.1M
    History used
    1,765 days
    2025-09-15: 1.1M2025-09-30: 813K2025-10-15: 944K2025-10-31: 894K2025-11-14: 926K2025-11-28: 949K2025-12-15: 899K2025-12-31: 760K2026-01-15: 858K2026-01-30: 896K2026-02-13: 909K2026-02-27: 823K2026-03-13: 924K2026-03-31: 894K2026-04-15: 852K2026-04-30: 998K2026-05-15: 1.5M2026-05-29: 1.7M2026-06-15: 1.9M2026-06-30: 2.1M2026-07-15: 2.2M2026-07-31: 2.1M2026-08-14: 2.4M2026-08-31: 2.3M2026-09-15: 2.7M
    the 15 Sep 2026 report24 earlier reportsnormal: 935K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  5. 11 Sep 2026Short interest and volume change

    had 2.3M shares sold short in the 31 Aug 2026 report, 2.2× the same report last year.

    Same report last year: 1.1M; its normal report is 935K.

    See the evidence
    This period
    2.3M (the 31 Aug 2026 report)
    Normal report (median of 24 earlier)
    935K
    Typical spread (median absolute deviation)
    98K
    How far from its usual level
    +9.7
    Same report last year
    1.1M
    History used
    1,750 days
    2025-08-29: 1.1M2025-09-15: 1.1M2025-09-30: 813K2025-10-15: 944K2025-10-31: 894K2025-11-14: 926K2025-11-28: 949K2025-12-15: 899K2025-12-31: 760K2026-01-15: 858K2026-01-30: 896K2026-02-13: 909K2026-02-27: 823K2026-03-13: 924K2026-03-31: 894K2026-04-15: 852K2026-04-30: 998K2026-05-15: 1.5M2026-05-29: 1.7M2026-06-15: 1.9M2026-06-30: 2.1M2026-07-15: 2.2M2026-07-31: 2.1M2026-08-14: 2.4M2026-08-31: 2.3M
    the 31 Aug 2026 report24 earlier reportsnormal: 935K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  6. 26 Aug 2026Short interest and volume change

    had 2.4M shares sold short in the 14 Aug 2026 report, 2.2× the same report last year.

    Same report last year: 1.1M; its normal report is 935K.

    See the evidence
    This period
    2.4M (the 14 Aug 2026 report)
    Normal report (median of 24 earlier)
    935K
    Typical spread (median absolute deviation)
    98K
    How far from its usual level
    +9.9
    Same report last year
    1.1M
    History used
    1,733 days
    2025-08-15: 1.1M2025-08-29: 1.1M2025-09-15: 1.1M2025-09-30: 813K2025-10-15: 944K2025-10-31: 894K2025-11-14: 926K2025-11-28: 949K2025-12-15: 899K2025-12-31: 760K2026-01-15: 858K2026-01-30: 896K2026-02-13: 909K2026-02-27: 823K2026-03-13: 924K2026-03-31: 894K2026-04-15: 852K2026-04-30: 998K2026-05-15: 1.5M2026-05-29: 1.7M2026-06-15: 1.9M2026-06-30: 2.1M2026-07-15: 2.2M2026-07-31: 2.1M2026-08-14: 2.4M
    the 14 Aug 2026 report24 earlier reportsnormal: 935K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  7. 12 Aug 2026Short interest and volume change

    had 2.1M shares sold short in the 31 Jul 2026 report, 1.9× the same report last year.

    Same report last year: 1.1M; its normal report is 935K.

    See the evidence
    This period
    2.1M (the 31 Jul 2026 report)
    Normal report (median of 24 earlier)
    935K
    Typical spread (median absolute deviation)
    98K
    How far from its usual level
    +8.3
    Same report last year
    1.1M
    History used
    1,719 days
    2025-07-31: 1.1M2025-08-15: 1.1M2025-08-29: 1.1M2025-09-15: 1.1M2025-09-30: 813K2025-10-15: 944K2025-10-31: 894K2025-11-14: 926K2025-11-28: 949K2025-12-15: 899K2025-12-31: 760K2026-01-15: 858K2026-01-30: 896K2026-02-13: 909K2026-02-27: 823K2026-03-13: 924K2026-03-31: 894K2026-04-15: 852K2026-04-30: 998K2026-05-15: 1.5M2026-05-29: 1.7M2026-06-15: 1.9M2026-06-30: 2.1M2026-07-15: 2.2M2026-07-31: 2.1M
    the 31 Jul 2026 report24 earlier reportsnormal: 935K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  8. 10 Jun 2026Short interest and volume change

    had 1.7M shares sold short in the 29 May 2026 report, 1.6× the same report last year.

    Same report last year: 1.1M; its normal report is 935K.

    See the evidence
    This period
    1.7M (the 29 May 2026 report)
    Normal report (median of 24 earlier)
    935K
    Typical spread (median absolute deviation)
    98K
    How far from its usual level
    +5.5
    Same report last year
    1.1M
    History used
    1,656 days
    2025-05-30: 1.1M2025-06-13: 1.1M2025-06-30: 1.3M2025-07-15: 1.3M2025-07-31: 1.1M2025-08-15: 1.1M2025-08-29: 1.1M2025-09-15: 1.1M2025-09-30: 813K2025-10-15: 944K2025-10-31: 894K2025-11-14: 926K2025-11-28: 949K2025-12-15: 899K2025-12-31: 760K2026-01-15: 858K2026-01-30: 896K2026-02-13: 909K2026-02-27: 823K2026-03-13: 924K2026-03-31: 894K2026-04-15: 852K2026-04-30: 998K2026-05-15: 1.5M2026-05-29: 1.7M
    the 29 May 2026 report24 earlier reportsnormal: 935K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  9. 10 Jun 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  10. 10 Jun 2026Filings record

    Director or officer change

  11. 28 May 2026Short interest and volume change

    had 1.5M shares sold short in the 15 May 2026 report, 1.4× the same report last year.

    Same report last year: 1.1M; its normal report is 935K.

    See the evidence
    This period
    1.5M (the 15 May 2026 report)
    Normal report (median of 24 earlier)
    935K
    Typical spread (median absolute deviation)
    98K
    How far from its usual level
    +3.9
    Same report last year
    1.1M
    History used
    1,642 days
    2025-05-15: 1.1M2025-05-30: 1.1M2025-06-13: 1.1M2025-06-30: 1.3M2025-07-15: 1.3M2025-07-31: 1.1M2025-08-15: 1.1M2025-08-29: 1.1M2025-09-15: 1.1M2025-09-30: 813K2025-10-15: 944K2025-10-31: 894K2025-11-14: 926K2025-11-28: 949K2025-12-15: 899K2025-12-31: 760K2026-01-15: 858K2026-01-30: 896K2026-02-13: 909K2026-02-27: 823K2026-03-13: 924K2026-03-31: 894K2026-04-15: 852K2026-04-30: 998K2026-05-15: 1.5M
    the 15 May 2026 report24 earlier reportsnormal: 935K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  12. 22 May 2026Insiders record

    Zeiher Bernhardt G (director) bought 5,000 shares of TRDA ($29,300) (dated 21 May 2026)

  13. 25 Nov 2025Insiders record

    BAKER FELIX (ten percent owner) and 3 other(s) bought 28,867 shares of TRDA ($261,824) (dated 24 Nov 2025)

  14. 13 Nov 2025Insiders record

    Baker Bros. Advisors (GP) LLC (ten percent owner) and 3 other(s) bought 178,044 shares of TRDA ($1.4M) (dated 12 Nov 2025)

  15. 19 Jun 2025Insiders record

    KIM PETER S (director) bought 50,000 shares of TRDA ($731,750) [amended] (dated 18 Jun 2025)

  16. 3 Jun 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  17. 3 Jun 2025Filings record

    Director or officer change

  18. 29 Apr 2025Filings record

    Restructuring costs announced

  19. 17 May 2024Insiders record

    KIM PETER S (director) bought 25,000 shares of TRDA ($364,750) (dated 16 May 2024)

  20. 11 May 2024Insiders record

    KIM PETER S (director) bought 4,476 shares of TRDA ($63,305) (dated 10 May 2024)

  21. 11 Apr 2024Insiders record

    KIM PETER S (director) bought 2,600 shares of TRDA ($35,282) (dated 10 Apr 2024)

  22. 2 Apr 2024Insiders record

    KIM PETER S (director) bought 1,512 shares of TRDA ($20,790) (dated 1 Apr 2024)

  23. 27 Mar 2024Insiders record

    KIM PETER S (director) bought 9,048 shares of TRDA ($122,898) (dated 26 Mar 2024)

  24. 22 Mar 2024Insiders record

    KIM PETER S (director) bought 2,732 shares of TRDA ($34,995) (dated 21 Mar 2024)

  25. 3 Jan 2024Filings record

    Director or officer change

  26. 12 Dec 2023Short interest and volume change

    had 1.8M shares sold short in the 30 Nov 2023 report, 1.6× the same report last year.

    Same report last year: 1.1M; its normal report is 1.2M.

    See the evidence
    This period
    1.8M (the 30 Nov 2023 report)
    Normal report (median of 24 earlier)
    1.2M
    Typical spread (median absolute deviation)
    83K
    How far from its usual level
    +4.8
    Same report last year
    1.1M
    History used
    745 days
    2022-11-30: 1.1M2022-12-15: 1.1M2022-12-30: 1.2M2023-01-13: 1.1M2023-01-31: 1.1M2023-02-15: 1.1M2023-02-28: 1.1M2023-03-15: 1.1M2023-03-31: 1.1M2023-04-14: 1.1M2023-04-28: 1.1M2023-05-15: 1.2M2023-05-31: 1.2M2023-06-15: 1.2M2023-06-30: 1.6M2023-07-14: 1.6M2023-07-31: 1.6M2023-08-15: 1.6M2023-08-31: 1.5M2023-09-15: 1.5M2023-09-29: 1.6M2023-10-13: 1.7M2023-10-31: 1.7M2023-11-15: 1.7M2023-11-30: 1.8M
    the 30 Nov 2023 report24 earlier reportsnormal: 1.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  27. 6 Dec 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  28. 6 Dec 2023Filings record

    Director or officer change

  29. 28 Nov 2023Short interest and volume change

    had 1.7M shares sold short in the 15 Nov 2023 report, 1.4× the same report last year.

    Same report last year: 1.1M; its normal report is 1.2M.

    See the evidence
    This period
    1.7M (the 15 Nov 2023 report)
    Normal report (median of 24 earlier)
    1.2M
    Typical spread (median absolute deviation)
    64K
    How far from its usual level
    +4.0
    Same report last year
    1.1M
    History used
    730 days
    2022-11-15: 1.1M2022-11-30: 1.1M2022-12-15: 1.1M2022-12-30: 1.2M2023-01-13: 1.1M2023-01-31: 1.1M2023-02-15: 1.1M2023-02-28: 1.1M2023-03-15: 1.1M2023-03-31: 1.1M2023-04-14: 1.1M2023-04-28: 1.1M2023-05-15: 1.2M2023-05-31: 1.2M2023-06-15: 1.2M2023-06-30: 1.6M2023-07-14: 1.6M2023-07-31: 1.6M2023-08-15: 1.6M2023-08-31: 1.5M2023-09-15: 1.5M2023-09-29: 1.6M2023-10-13: 1.7M2023-10-31: 1.7M2023-11-15: 1.7M
    the 15 Nov 2023 report24 earlier reportsnormal: 1.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  30. 10 Nov 2023Short interest and volume change

    had 1.7M shares sold short in the 31 Oct 2023 report, 1.6× the same report last year.

    Same report last year: 1.1M; its normal report is 1.2M.

    See the evidence
    This period
    1.7M (the 31 Oct 2023 report)
    Normal report (median of 24 earlier)
    1.2M
    Typical spread (median absolute deviation)
    54K
    How far from its usual level
    +4.8
    Same report last year
    1.1M
    History used
    715 days
    2022-10-31: 1.1M2022-11-15: 1.1M2022-11-30: 1.1M2022-12-15: 1.1M2022-12-30: 1.2M2023-01-13: 1.1M2023-01-31: 1.1M2023-02-15: 1.1M2023-02-28: 1.1M2023-03-15: 1.1M2023-03-31: 1.1M2023-04-14: 1.1M2023-04-28: 1.1M2023-05-15: 1.2M2023-05-31: 1.2M2023-06-15: 1.2M2023-06-30: 1.6M2023-07-14: 1.6M2023-07-31: 1.6M2023-08-15: 1.6M2023-08-31: 1.5M2023-09-15: 1.5M2023-09-29: 1.6M2023-10-13: 1.7M2023-10-31: 1.7M
    the 31 Oct 2023 report24 earlier reportsnormal: 1.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  31. 25 Oct 2023Short interest and volume change

    had 1.7M shares sold short in the 13 Oct 2023 report, 1.5× the same report last year.

    Same report last year: 1.1M; its normal report is 1.1M.

    See the evidence
    This period
    1.7M (the 13 Oct 2023 report)
    Normal report (median of 24 earlier)
    1.1M
    Typical spread (median absolute deviation)
    46K
    How far from its usual level
    +4.4
    Same report last year
    1.1M
    History used
    697 days
    2022-10-14: 1.1M2022-10-31: 1.1M2022-11-15: 1.1M2022-11-30: 1.1M2022-12-15: 1.1M2022-12-30: 1.2M2023-01-13: 1.1M2023-01-31: 1.1M2023-02-15: 1.1M2023-02-28: 1.1M2023-03-15: 1.1M2023-03-31: 1.1M2023-04-14: 1.1M2023-04-28: 1.1M2023-05-15: 1.2M2023-05-31: 1.2M2023-06-15: 1.2M2023-06-30: 1.6M2023-07-14: 1.6M2023-07-31: 1.6M2023-08-15: 1.6M2023-08-31: 1.5M2023-09-15: 1.5M2023-09-29: 1.6M2023-10-13: 1.7M
    the 13 Oct 2023 report24 earlier reportsnormal: 1.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  32. 12 Oct 2023Short interest and volume change

    had 1.6M shares sold short in the 29 Sep 2023 report, 1.5× the same report last year.

    Same report last year: 1.1M; its normal report is 1.1M.

    See the evidence
    This period
    1.6M (the 29 Sep 2023 report)
    Normal report (median of 24 earlier)
    1.1M
    Typical spread (median absolute deviation)
    44K
    How far from its usual level
    +3.7
    Same report last year
    1.1M
    History used
    683 days
    2022-09-30: 1.1M2022-10-14: 1.1M2022-10-31: 1.1M2022-11-15: 1.1M2022-11-30: 1.1M2022-12-15: 1.1M2022-12-30: 1.2M2023-01-13: 1.1M2023-01-31: 1.1M2023-02-15: 1.1M2023-02-28: 1.1M2023-03-15: 1.1M2023-03-31: 1.1M2023-04-14: 1.1M2023-04-28: 1.1M2023-05-15: 1.2M2023-05-31: 1.2M2023-06-15: 1.2M2023-06-30: 1.6M2023-07-14: 1.6M2023-07-31: 1.6M2023-08-15: 1.6M2023-08-31: 1.5M2023-09-15: 1.5M2023-09-29: 1.6M
    the 29 Sep 2023 report24 earlier reportsnormal: 1.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  33. 13 Sep 2023Short interest and volume change

    had 1.5M shares sold short in the 31 Aug 2023 report, 1.4× the same report last year.

    Same report last year: 1.1M; its normal report is 1.1M.

    See the evidence
    This period
    1.5M (the 31 Aug 2023 report)
    Normal report (median of 24 earlier)
    1.1M
    Typical spread (median absolute deviation)
    39K
    How far from its usual level
    +3.6
    Same report last year
    1.1M
    History used
    654 days
    2022-08-31: 1.1M2022-09-15: 1.1M2022-09-30: 1.1M2022-10-14: 1.1M2022-10-31: 1.1M2022-11-15: 1.1M2022-11-30: 1.1M2022-12-15: 1.1M2022-12-30: 1.2M2023-01-13: 1.1M2023-01-31: 1.1M2023-02-15: 1.1M2023-02-28: 1.1M2023-03-15: 1.1M2023-03-31: 1.1M2023-04-14: 1.1M2023-04-28: 1.1M2023-05-15: 1.2M2023-05-31: 1.2M2023-06-15: 1.2M2023-06-30: 1.6M2023-07-14: 1.6M2023-07-31: 1.6M2023-08-15: 1.6M2023-08-31: 1.5M
    the 31 Aug 2023 report24 earlier reportsnormal: 1.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  34. 25 Aug 2023Short interest and volume change

    had 1.6M shares sold short in the 15 Aug 2023 report, 1.4× the same report last year.

    Same report last year: 1.1M; its normal report is 1.1M.

    See the evidence
    This period
    1.6M (the 15 Aug 2023 report)
    Normal report (median of 24 earlier)
    1.1M
    Typical spread (median absolute deviation)
    28K
    How far from its usual level
    +3.9
    Same report last year
    1.1M
    History used
    638 days
    2022-08-15: 1.1M2022-08-31: 1.1M2022-09-15: 1.1M2022-09-30: 1.1M2022-10-14: 1.1M2022-10-31: 1.1M2022-11-15: 1.1M2022-11-30: 1.1M2022-12-15: 1.1M2022-12-30: 1.2M2023-01-13: 1.1M2023-01-31: 1.1M2023-02-15: 1.1M2023-02-28: 1.1M2023-03-15: 1.1M2023-03-31: 1.1M2023-04-14: 1.1M2023-04-28: 1.1M2023-05-15: 1.2M2023-05-31: 1.2M2023-06-15: 1.2M2023-06-30: 1.6M2023-07-14: 1.6M2023-07-31: 1.6M2023-08-15: 1.6M
    the 15 Aug 2023 report24 earlier reportsnormal: 1.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  35. 10 Aug 2023Short interest and volume change

    had 1.6M shares sold short in the 31 Jul 2023 report, 1.3× the same report last year.

    Same report last year: 1.2M; its normal report is 1.1M.

    See the evidence
    This period
    1.6M (the 31 Jul 2023 report)
    Normal report (median of 24 earlier)
    1.1M
    Typical spread (median absolute deviation)
    28K
    How far from its usual level
    +4.0
    Same report last year
    1.2M
    History used
    623 days
    2022-07-29: 1.2M2022-08-15: 1.1M2022-08-31: 1.1M2022-09-15: 1.1M2022-09-30: 1.1M2022-10-14: 1.1M2022-10-31: 1.1M2022-11-15: 1.1M2022-11-30: 1.1M2022-12-15: 1.1M2022-12-30: 1.2M2023-01-13: 1.1M2023-01-31: 1.1M2023-02-15: 1.1M2023-02-28: 1.1M2023-03-15: 1.1M2023-03-31: 1.1M2023-04-14: 1.1M2023-04-28: 1.1M2023-05-15: 1.2M2023-05-31: 1.2M2023-06-15: 1.2M2023-06-30: 1.6M2023-07-14: 1.6M2023-07-31: 1.6M
    the 31 Jul 2023 report24 earlier reportsnormal: 1.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  36. 10 Aug 2023Filings record

    Director or officer change

  37. 26 Jul 2023Short interest and volume change

    had 1.6M shares sold short in the 14 Jul 2023 report, 1.1× the same report last year.

    Same report last year: 1.5M; its normal report is 1.1M.

    See the evidence
    This period
    1.6M (the 14 Jul 2023 report)
    Normal report (median of 24 earlier)
    1.1M
    Typical spread (median absolute deviation)
    28K
    How far from its usual level
    +4.3
    Same report last year
    1.5M
    History used
    606 days
    2022-07-15: 1.5M2022-07-29: 1.2M2022-08-15: 1.1M2022-08-31: 1.1M2022-09-15: 1.1M2022-09-30: 1.1M2022-10-14: 1.1M2022-10-31: 1.1M2022-11-15: 1.1M2022-11-30: 1.1M2022-12-15: 1.1M2022-12-30: 1.2M2023-01-13: 1.1M2023-01-31: 1.1M2023-02-15: 1.1M2023-02-28: 1.1M2023-03-15: 1.1M2023-03-31: 1.1M2023-04-14: 1.1M2023-04-28: 1.1M2023-05-15: 1.2M2023-05-31: 1.2M2023-06-15: 1.2M2023-06-30: 1.6M2023-07-14: 1.6M
    the 14 Jul 2023 report24 earlier reportsnormal: 1.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  38. 13 Jul 2023Short interest and volume change

    had 1.6M shares sold short in the 30 Jun 2023 report, 1.1% below the same report last year.

    Same report last year: 1.6M; its normal report is 1.1M.

    See the evidence
    This period
    1.6M (the 30 Jun 2023 report)
    Normal report (median of 24 earlier)
    1.1M
    Typical spread (median absolute deviation)
    28K
    How far from its usual level
    +4.1
    Same report last year
    1.6M
    History used
    592 days
    2022-06-30: 1.6M2022-07-15: 1.5M2022-07-29: 1.2M2022-08-15: 1.1M2022-08-31: 1.1M2022-09-15: 1.1M2022-09-30: 1.1M2022-10-14: 1.1M2022-10-31: 1.1M2022-11-15: 1.1M2022-11-30: 1.1M2022-12-15: 1.1M2022-12-30: 1.2M2023-01-13: 1.1M2023-01-31: 1.1M2023-02-15: 1.1M2023-02-28: 1.1M2023-03-15: 1.1M2023-03-31: 1.1M2023-04-14: 1.1M2023-04-28: 1.1M2023-05-15: 1.2M2023-05-31: 1.2M2023-06-15: 1.2M2023-06-30: 1.6M
    the 30 Jun 2023 report24 earlier reportsnormal: 1.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  39. 8 Jun 2023Filings record

    Director or officer change

  40. 4 Apr 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

Showing the newest 40 of 57 entries; narrow the window or the kind of data to see older ones.

Not listed: 167 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001689375
Ticker
TRDA
Domain
entradatx.com
Employer name
Entrada Therapeutics, Inc. (1 unverified)
Hq location
MA|BOSTON|02210 (1 unverified)
Name
CycloPorters, Inc., Document, Entrada Securities Corporation, Entrada Therapeutics, Inc. and 2 more
  • DOL H-1B labor condition applications and PERM certifications89 data points18 May 2020 to 14 Sep 2026
  • SEC Form 13F institutional holdings180 data points31 Dec 2021 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)76 records10 Nov 2016 to 5 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)386 data points31 Dec 2019 to 31 Oct 2026
  • SEC Form 4 insider transactions124 records, 324 data points4 Nov 2021 to 9 Sep 2026
  • FINRA short interest (twice monthly)356 data points15 Nov 2021 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)2542 data points29 Oct 2021 to 20 Nov 2026